Skip Nav Destination
1-4 of 4
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Two-Year Safety and Tolerability of Velaglucerase Alfa in Patients with Type 1 Gaucher Disease, Including Patients Switched From Imiglucerase: Phase III Trial HGT-GCB-039 and Extension,
A Mehta, H Ben Turkia, DE Gonzalez, M Kabra, EA Lukina, P Giraldo, I Kisinovsky, A Bavdekar, M-F Ben Dridi, N Gupta, PS Kishnani, EK Sureshkumar, N Barton, N Wang, E Crombez, K Bhirangi, A Zimran
Blood (2011) 118 (21): 3214.
Blood (1994) 84 (7): 2374–2375.
Home treatment with intravenous enzyme replacement therapy for Gaucher disease: an international collaborative study of 33 patients
Blood (1993) 82 (4): 1107–1109.
Blood (1992) 79 (7): 1662–1666.